Skip to main content
. 2022 Nov 1;12:18412. doi: 10.1038/s41598-022-22025-2

Table 2.

Evidence profile with GRADE pro for the three meta-analyses.

Certainty assessment No. of subjects Size of the effect Quality of evidence
N of studies Study design Risk of bias Inconsistency Indirect evidence Imprecision Other considerations MetS+ MetS− Difference of averages (95% CI)
Meta-analysis 1
n = 56 Observational studies Very serious It is not serious It is not serious Dose–response gradient 91,845 259,931 0,57 (0.54–0.61)

⨁◯◯◯

Very low

Meta-analysis 2
n = 17 Observational studies Very serious It is not serious It is not serious Dose–response gradient 19,165 86,883 0.53 (0.45–0.62)

⨁◯◯◯

Very low

Meta-analysis 3
n = 15 Observational studies Very serious It is not serious It is not serious Dose–response gradient 14,823 43,471 0.57 (0.48–0.66)

⨁◯◯◯

Very low

MetS metabolic syndrome, CI confidence interval.